Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anuj Kumar Saini
Observed names:
Anuj K Saini,
Anuj Saini,
Anuj Kumar Saini
Institutions:
Dr. Reddy's Laboratories (India),
Dr. Reddy's Laboratories Ltd. (Russia)
Observed institutions:
Dr. Reddy's Laboratories (India),
Zydus Lifesciences Limited (India),
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research,
Dr. Reddy's Laboratories Ltd. (Russia)
ORCID:
0000-0001-7131-4267
Observed ORCID:
0000-0001-7131-4267
OpenAlex ID:
A5008801836
Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy
2007
·
Anuj Kumar Saini
, Arun Kumar H.S.
, et al.
·
European Journal of Pharmacology
·
76
Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs
2022
·
Di Wu
, Maitri Sanghavi
, et al.
·
Pharmaceutical Research
·
52
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives
2023
·
Sivacharan Kollipara
, Frederico S. Martins
, et al.
·
Journal of Pharmaceutical Sciences
·
27
Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP‐1, GIP, and Glucagon Agonists
2026
·
Mohammed Shareef Khan
, Utkarsh Bhutani
, et al.
·
Journal of Peptide Science
·
5
New era in bioequivalence global harmonization through ICH M13 initiative: critical review on new concepts, alternative approaches for high-risk products
2025
·
Mohammed Shareef Khan
, Sohel Mohammed Khan
, et al.
·
Xenobiotica
·
3
Comparative overview of biosimilar regulatory frameworks and international harmonization trends
2026
·
Mohammed Shareef Khan
, Sohel Mohammed Khan
, et al.
·
Expert Opinion on Biological Therapy
·
1
Leveraging Model Integrated Bioequivalence (MIBE) to Address Regulatory Concerns and Waive Repeat Bioequivalence Studies—A Case Study with Clopidogrel
2025
·
Mathangi Gopalakrishnan
, Adithya Karthik Bhattiprolu
, et al.
·
The Journal of Clinical Pharmacology
·
1
PDF
Exploring Additional Strength Biowaiver Perspectives in the ICH M13B Framework for Immediate Release Solid Oral Dosage Forms: Opportunities & Challenges
2025
·
Rajkumar Boddu
, Arvind Rachapally
, et al.
·
Therapeutic Innovation & Regulatory Science
·
1
A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus.
2026
·
Dilip Shah
, Mamidala Venkata Ramamohan
, et al.
·
Journal of Clinical Endocrinology and Metabolism
PDF
Pharmacokinetic bioequivalence of semaglutide injection in healthy adults under fasting conditions: A randomized study
2026
·
Sohel Mohammed Khan
, Mohammed Shareef Khan
, et al.
·
Journal of Clinical and Translational Research
PDF
Development of a novel rabeprazole modified release formulation to reduce the dosing frequency: A trial and triumph with physiologically based biopharmaceutics modeling
2026
·
Harika Maddukuri
, Rajkumar Boddu
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden?
2026
·
Sivacharan Kollipara
, Rajkumar Boddu
, et al.
·
Pharmaceutics
Correction: Exploring Additional Strength Biowaiver Perspectives in the ICH M13B Framework for Immediate Release Solid Oral Dosage Forms: Opportunities & Challenges
2026
·
Rajkumar Boddu
, Arvind Rachapally
, et al.
·
Therapeutic Innovation & Regulatory Science
PDF
Practical insights into additional strength biowaivers for oral solid dosage forms: current requirements by major regulatory agencies and path towards harmonization
2026
·
Chandra Teja Uppuluri
, Adithya Karthik Bhattiprolu
, et al.
·
Xenobiotica
Physiologically-based pharmacokinetic modeling for pharmaceuticals—institute, industry and agencies perspective
2024
·
Ajay S Lale
, Maitri S Sanghavi
, et al.
·
Institute of Physics eBooks
PDF
Show more works
View as search
Works count:
15
Citation count:
166
H-index:
4
I10-index:
3
Year
Topic
Type